Oncosec Medical Incorporated Revenue Growth Rates (ONCS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Oncosec Medical Incorporated  (NASDAQ: ONCS)
 

ONCS's Revenue Growth by Quarter and Year

Oncosec Medical Incorporated's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ONCS Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter July -
3rd Quarter April -
2nd Quarter January 0.00
1st Quarter October 0.00
FY 0.00





ONCS Revenue second quarter 2023 Y/Y Growth Comment
Oncosec Medical Incorporated in the second quarter 2023 recorded of $ 0.00 millions.

According to the results reported in the second quarter 2023, Oncosec Medical Incorporated achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Oncosec Medical Incorporated' s Revenue no change of 0% ranks overall at the positon no. in the second quarter 2023.


ONCS Revenue ( Y/Y Growth %) 2023
 2022 2021 2020
4th Quarter July - - - -
3rd Quarter April - - - -
2nd Quarter January - - - -
1st Quarter October - - - -
FY   - - - -

Financial Statements
Oncosec Medical Incorporated's second quarter 2023 Revenue $ 0.00 millions ONCS's Income Statement
Oncosec Medical Incorporated's second quarter 2022 Revenue $ 0.00 millions Quarterly ONCS's Income Statement


ONCS Revenue (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
4th Quarter July - - - -
3rd Quarter April - - - -
2nd Quarter January - - - -
1st Quarter October - - - -
FY (Year on Year)   - - - -


Back to ONCS Growth rate Comparisons >> Back to ONCS Growth rate Comparisons >>


Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Oncosec Medical Incorporated's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ONCS's II. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ONCS's II. Quarter Q/Q Revenue Comment


Oncosec Medical Incorporated's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jan 31 2023)		 12 Months Ending
(Oct 31 2022)		 12 Months Ending
(Jul 31 2022)		 12 Months Ending
(Apr 30 2022)		 12 Months Ending
(Jan 31 2022)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Jan 31 2023 period, Oncosec Medical Incorporated's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Oncosec Medical Incorporated achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Jan 31 2023 period, Oncosec Medical Incorporated's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Oncosec Medical Incorporated achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ONCS's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Jan 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jan 31 2023
Medtronic Plc-0.46%$ -0.464 millions
Champions Oncology Inc -3.18%$ -3.184 millions
Johnson and Johnson-4.43%$ -4.427 millions
Rafael Holdings Inc-5.41%$ -5.405 millions
Illumina Inc -9.59%$ -9.591 millions
Heartsciences Inc -27.78%$ -27.778 millions
Zeo Scientifix Inc -33.08%$ -33.076 millions
Enzo Biochem Inc-77.93%$ -77.930 millions


About Oncosec Medical Incorporated Revenue Growth Rates (ONCS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Oncosec Medical Inc (CIK 1444307).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-23-007478
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Oncosec Medical Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.